A novel type of congenital hypochromic anemia associated with a nonsense mutation in the STEAP3/TSAP6 gene

Blood

Volumn 118, Issue 25, 2011, Pages 6660-6666

  Grandchamp, Bernard ^a,b   Hetet, Gilles ^a   Kannengiesser, Caroline ^a,b   Oudin, Claire ^a   Beaumont, Carole ^a,b   Rodrigues Ferreira, Sylvie ^c   Amson, Robert ^c   Telerman, Adam ^c   Nielsen, Peter ^d   Kohne, Elisabeth ^e   Balser, Christina ^f   Heimpel, Hermann ^e  

^a BICHAT HOSPITAL   (France)

^b INSERM   (France)

^c Ecole Normale Superieure de Cachan   (France)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e UNIVERSITY OF ULM   (Germany)

^f Practice of Hematology/Oncology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; MESSENGER RNA; PROTEIN STEAP3 TSAP6; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE SEVERITY; FAMILY STUDY; FEMALE; GENE EXPRESSION; GENETIC CODE; HETEROZYGOSITY; HUMAN; IRON DEFICIENCY ANEMIA; MALE; MICROCYTIC ANEMIA; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; STATISTICAL SIGNIFICANCE;

EID: 84055177590     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-01-329011     Document Type: Article

References (25)

1. Telerman A, Amson R. The molecular programme of tumour reversion: the steps beyond malignant transformation. Nat Rev Cancer. 2009;9(3):206-216.
2. Amson RB, Nemani M, Roperch JP, et al. Isolation of 10 differentially expressed cDNAs in p53-induced apoptosis: activation of the vertebrate homologue of the drosophila seven in absentia gene. Proc Natl Acad Sci U S A. 1996;93(9):3953-3957. (Pubitemid 26144229)
3. Passer BJ, Nancy-Portebois V, Amzallag N, et al. The p53-inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinase. Proc Natl Acad Sci U S A. 2003;100(5):2284-2289. (Pubitemid 36297491)
4. Amzallag N, Passer BJ, Allanic D, et al. TSAP6 facilitates the secretion of translationally controlled tumor protein/histamine-releasing factor via a nonclassical pathway. J Biol Chem. 2004;279(44):46104-46112. (Pubitemid 39491604)
5. Lespagnol A, Duflaut D, Beekman C, et al. Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice. Cell Death Differ. 2008;15(11):1723-1733.
6. Levine AJ, Hu W, Feng Z. The P53 pathway: what questions remain to be explored? Cell Death Differ. 2006;13(6):1027-1036.
7. Yu X, Harris SL, Levine AJ. The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res. 2006;66(9):4795-4801.
8. Ohgami RS, Campagna DR, Greer EL, et al. Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. Nat Genet. 2005;37(11):1264-1269. (Pubitemid 41568711)
9. Caillot F, Daveau R, Daveau M, et al. Downregulated expression of the TSAP6 protein in liver is associated with a transition from cirrhosis to hepatocellular carcinoma. Histopathology. 2009;54(3):319-327.
10. Iolascon A, De Falco L, Beaumont C. Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis. Haematologica. 2009;94(3):395-408.
11. Andrews NC, Schmidt PJ. Iron homeostasis. Annu Rev Physiol. 2007;69:69-85. (Pubitemid 46457636)
12. Lambe T, Simpson RJ, Dawson S, et al. Identification of a Steap3 endosomal targeting motif essential for normal iron metabolism. Blood. 2009;113(8):1805-1808.
13. Gouya L, Puy H, Robreau AM, et al. The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH. Nat Genet. 2002;30(1):27-28.
14. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(DeltaDelta C(T)) Method. Methods. 2001;25(4):402-408. (Pubitemid 34164012)
15. Serre D, Gurd S, Ge B, et al. Differential allelic expression in the human genome: a robust approach to identify genetic and epigenetic cis-acting mechanisms regulating gene expression. PLoS Genet. 2008;4(2):e1000006.
16. Hentze MW, Kulozik AE. A perfect message: RNA surveillance and nonsense-mediated decay. Cell. 1999;96(3):307-310. (Pubitemid 29077583)
17. Emilsson V, Thorleifsson G, Zhang B, et al. Genetics of gene expression and its effect on disease. Nature. 2008;452(7186):423-428. (Pubitemid 351450845)
18. Skelly DA, Ronald J, Akey JM. Inherited variation in gene expression. Annu Rev Genomics Hum Genet. 2009;10:313-332.
19. Zhang Y, Rohde C, Reinhardt R, Voelcker-Rehage C, Jeltsch A. Non-imprinted allele-specific DNA methylation on human autosomes. Genome Biol. 2009;10(12):R138.
20. Wasserman NF, Aneas I, Nobrega MA. An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer. Genome Res. 2010;20(9):1191-1197.
21. Camaschella C. Hereditary sideroblastic anemias: pathophysiology, diagnosis, and treatment. Semin Hematol. 2009;46(4):371-377.
22. Heimpel H, Forteza-Vila J, Queisser W, Spiertz E. Electron and light microscopic study of the erythroblasts of patients with congenital dyserythropoietic anemia. Blood. 1971;37(3):299-310.
23. Wilmotte R, Marechal J, Morle L, et al. Low expression allele alpha LELY of red cell spectrin is associated with mutations in exon 40 (alpha V/41 polymorphism) and intron 45 and with partial skipping of exon 46. J Clin Invest. 1993;91(5):2091-2096. (Pubitemid 23141482)
24. Delaunay J. Molecular basis of red cell membrane disorders. Acta Haematol. 2002;108(4):210-218. (Pubitemid 35356697)
25. Lecha M, Puy H, Deybach JC. Erythropoietic protoporphyria. Orphanet J Rare Dis. 2009;4:19.